Pathology of asthma and its clinical implications

The Journal of Allergy and Clinical Immunology

Volumn 92, Issue 1 PART 2, 1993, Pages 148-154

  Beasley, R ^a,b   Burgess, C ^a,b   Crane, J ^a,b   Pearce, N ^a,b   Roche, W ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL SODIUM;

ALLERGIC ASTHMA; ASTHMA; BRONCHUS BIOPSY; CELL INFILTRATION; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG LAVAGE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPUTUM EXAMINATION;

ASTHMA; BIOPSY; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIUM; HUMAN; MUCOUS MEMBRANE; SPUTUM;

EID: 0027249231     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(93)90097-Y     Document Type: Article

References (46)

1. The pathology of bronchial asthma
2. A clinical and pathological study of fatal cases of status asthmaticus
3. The pathology of asthma with special reference to changes in the bronchial mucosa
4. Anatomopathologic changes in the bronchial walls in chronic inflammation, with special reference to the basement membrane, in the course of bronchial asthma
5. Hyperplasia of bronchial muscle in asthma
6. Uber Bronchiolitis exsudativa und ihr Verhaltnis zum Asthma nervosum
7. The shedding of the mucosa of the bronchial tree in asthma
8. Zur Kentniss des bronchial Asthma
9. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory disease
10. Cellular events in the bronchi in mild asthma and after bronchial provocation
11. Bronchoalveolar mast cell in extrinsic asthma: a mechanism for the initiation of antigen-specific bronchoconstriction
12. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity
13. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness
14. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation
15. 2 into human airways during acute allergen challenge
16. Fluid dynamics during bronchoalveolar lavage
17. Bronchial biopsy in chronic bronchitis and asthma
18. Some histological changes in chronic bronchitis and asthma
19. Damage of the airway epithelium and bronchial reactivity in patients with asthma
20. Scanning electron microscopic studies of bronchial mucosa before and during treatment with beclomethasone diproprionate inhalations
21. 1 receptor antagonist in asthmatic airways
22. Subepithelial fibrosis in the bronchi of asthmatics
23. Rate of decline of lung function in subjects with asthma
24. Asthma mortality in New Zealand, 1908–1986: an unreported epidemic in the 1940s–1950s
25. Rise and fall of asthma mortality in England and Wales in relation to use of pressurized aerosols
26. Asthma mortality: why the United States was spared the epidemic of deaths due to asthma
27. Seventy-five deaths in asthmatics prescribed home nebulizers
28. Has the change to beta agonists combined with oral theophyllines increased cases of fatal asthma?
29. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977–1981
30. Prescribed fenoterol and death from asthma in New Zealand, 1981–1987: a further case-control study
31. Confounding by severity does not explain the association between fenoterol and asthma death
32. The use of β-agonists and the risk of death and near death from asthma
33. The development of drug tolerance to beta 2 adrenergic agents
34. Regular inhaled beta agonist treatment in bronchial asthma
35. Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics
36. Spirometry and blood gas tensions in bronchial asthma and chronic bronchitis
37. A comparison of the cardiovascular and hypokalemic effects of inhaled salbutamol, fenoterol, and isoprenaline
38. Patients at risk for dying of asthma: New Zealand experience
39. The cardiotoxicity of isoprenaline during hypoxia
40. Is current treatment increasing asthma mortality and morbidity?
41. Trends in the hospital care of acute childhood asthma 1970-8: a regional study
42. The severity of asthma in children admitted to hospital a 20-year review
43. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline
44. Effect of long-term treatment with inhaled corticosteroids and beta agonists on the bronchial hyperresponsiveness in children with asthma
45. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline